Fibrinogen
EstablishedFibrinogen is a key clotting protein, actively corrected early in modern trauma resuscitation protocols.
Fibrinogen is a key clotting protein, and low levels during severe bleeding are now treated proactively and early, since fibrinogen tends to run out before other clotting factors during massive blood loss.
Fibrinogen is a plasma protein converted to fibrin during the final step of blood clotting, essential for forming a stable clot; it is also an acute-phase reactant that rises with inflammation.
Low fibrinogen indicates consumption (as in disseminated intravascular coagulation), impaired liver synthesis, or massive blood loss, all of which increase bleeding risk; it is a critical target in trauma resuscitation.
Measured via serum assay (Clauss method most common); critically low fibrinogen during massive bleeding is now actively corrected with fibrinogen concentrate or cryoprecipitate as part of modern damage-control resuscitation protocols.
Fibrinogen is often the first clotting factor to become critically depleted in major hemorrhage, making early fibrinogen repletion (rather than waiting for standard coagulation panel results) a priority in current trauma and massive transfusion protocols.
Often the first factor depleted in major hemorrhage, prioritized for early repletion in massive transfusion protocols.
- General trauma resuscitation and hematology reference literature on fibrinogen repletion in massive transfusion protocols.